Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

19 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Breast Cancer NCT00070564 Pre-Study - SOUTHWEST ONCOLOGY GROUP S0221 BREAST CANCER PRESTUDY FORM - 2046547v3.0 - SOUTHWEST ONCOLOGY GROUP S0221 BREAST CANCER PRESTUDY FORM

- 09/01/2015 - 1 Formulaire, 6 Groupes Item, 61 Eléments de données, 1 Langue
Groupes Item: Header, PATIENT CHARACTERISTICS, DISEASE DESCRIPTION, LABORATORY VALUES, PRIOR TREATMENT RELATED TO THIS CANCER, Comments Module
SOUTHWEST ONCOLOGY GROUP S0221 BREAST CANCER PRESTUDY FORM Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A6788C86-182E-5088-E034-0003BA0B1A09

Pre-Study Breast Cancer SWOG S0307 NCT00127205

- 26/08/2015 - 1 Formulaire, 10 Groupes Item, 46 Eléments de données, 1 Langue
Groupes Item: Administrative documentation, DISEASE DESCRIPTION, LABORATORY VALUES, CONSENT FOR SUBMISSION AND BANKING, PATIENT CHARACTERISTICS, DISEASE DESCRIPTION, TREATMENT WITH STATINS, PATIENT PREFERENCE, PRIOR TREATMENT RELATED TO THIS CANCER, SYSTEMIC TREATMENT FOR THIS CANCER
SOUTHWEST ONCOLOGY GROUP S0307 PRESTUDY FORM Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast SOUTHWEST ONCOLOGY GROUP S0307 PRESTUDY FORM Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DEA0B902-CDD3-54E6-E034-0003BA12F5E7

Breast Cancer SWOG baseline tumor assessment NCT00075764 - BASELINE TUMOR ASSESSMENT Breast cancer SWOG S0226 NCT00075764

- 25/03/2015 - 1 Formulaire, 4 Groupes Item, 20 Eléments de données, 1 Langue
Groupes Item: Header, TARGET LESIONS, NON-TARGET DISEASE, Other tests
SOUTHWEST ONCOLOGY GROUP BASELINE TUMOR ASSESSMENT FORM (S0226) S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer NCT00075764 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C322202A-32BF-25B7-E034-0003BA12F5E7

Breast Cancer Goserelin in Preventing Ovarian Failure NCT00068601 SWOG S0230 - PreStudy

- 24/06/2017 - 1 Formulaire, 3 Groupes Item, 17 Eléments de données, 1 Langue
Groupes Item: Disease Description, Laboratory Tests, CCRR MODULE
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer https://clinicaltrials.gov/ct2/show/NCT00068601 Breast Cancer NCT00068601 Pre-Study - Southwest Oncology Group PreStudy (S0230) - 2170510v3.0

Breast Cancer NCT01272037 Pre-Study - S1007 Prestudy Form (45282) - 3141026v1.0 - S1007 Prestudy Form (45282)

- 09/01/2015 - 1 Formulaire, 5 Groupes Item, 40 Eléments de données, 1 Langue
Groupes Item: Header Module, PATIENT AND DISEASE DESCRIPTION, ADDITIONAL PRESTUDY DATA, PRIOR TREATMENT RELATED TO THIS CANCER, Comments
S1007 Prestudy Form (45282) Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90DB6C43-AEA1-137D-E040-BB89AD432116

Breast Cancer NCT01101438 Pre-Study - NCIC MA.32 Baseline Report - 3027459v1.0 - NCIC MA.32 Baseline Report

- 09/01/2015 - 1 Formulaire, 13 Groupes Item, 54 Eléments de données, 1 Langue
Groupes Item: TOBACCO SMOKING HISTORY - BASELINE, ALCOHOL CONSUMPTION - QUESTION, BILATERAL BREAST CARCINOMA - QUESTION, BILATERAL BREAST CARCINOMA, BASELINE ADVERSE EVENTS - QUESTION, BASELINE ADVERSE EVENTS, CARDIOVASCULAR HISTORY - QUESTION, CARDIOVASCULAR HISTORY, BASELINE CONCOMITANT MEDICATIONS, ADJUVANT RADIATION THERAPY, SYSTEMIC THERAPY, MAJOR MEDICAL PROBLEMS AT BASELINE, OTHER CLINICAL TRIAL PARTICIPATION
NCIC MA.32 Baseline Report A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=81E21D11-128C-1198-E040-BB89AD434372

Breast Cancer NCT00103233 Pre-Study - SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0347) - 2412719v1.0 - SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0347)

- 09/01/2015 - 1 Formulaire, 6 Groupes Item, 36 Eléments de données, 1 Langue
Groupes Item: Header, PATIENT CHARACTERISTICS, MENOPAUSAL STATUS, DISEASE DESCRIPTION, PRIOR TREATMENT RELATED TO THIS CANCER, Comments
SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0347) Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=01ECF016-02E2-1026-E044-0003BA3F9857

Breast Cancer NCT00382018 Pre-Study - SOUTHWEST ONCOLOGY GROUP S0500 Prestudy Form - 2436725v1.0 - SOUTHWEST ONCOLOGY GROUP S0500 Prestudy Form

- 09/01/2015 - 1 Formulaire, 6 Groupes Item, 37 Eléments de données, 1 Langue
Groupes Item: Header, PATIENT CHARACTERISTICS, MENOPAUSAL STATUS, DISEASE DESCRIPTION, PRIOR TREATMENT RELATED TO THIS CANCER, Comments
SOUTHWEST ONCOLOGY GROUP S0500 Prestudy Form Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=07D022D9-F34F-20A8-E044-0003BA3F9857

Breast Cancer NCT01272037 Pre-Study - S1007 Prestudy Form - Randomized Study (6230) - 3141162v1.0 - S1007 Prestudy Form - Randomized Study (6230)

- 09/01/2015 - 1 Formulaire, 3 Groupes Item, 18 Eléments de données, 1 Langue
Groupes Item: Header Module, PATIENT AND DISEASE DESCRIPTION, Comments
S1007 Prestudy Form - Randomized Study (6230) Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90DE259F-A7AB-E9EB-E040-BB89AD436D98

Breast Cancer NCT00068601 Pre-Study - Southwest Oncology Group Ovarian Function Assessment (S0230) - 2170708v3.0 - Southwest Oncology Group Ovarian Function Assessment (S0230)

- 09/01/2015 - 1 Formulaire, 3 Groupes Item, 25 Eléments de données, 1 Langue
Groupes Item: Menstrual cycle, Laboratory Test, CCRR MODULE
Southwest Oncology Group Ovarian Function Assessment (S0230) Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BEA6A9CC-6D74-0D93-E034-0003BA12F5E7

Breast Cancer NCT00068601 Pre-Study - Southwest Oncology Group BASELINE ASSESSMENT FORM (S0230) - 2170664v3.0 - Southwest Oncology Group BASELINE ASSESSMENT FORM (S0230)

- 09/01/2015 - 1 Formulaire, 2 Groupes Item, 14 Eléments de données, 1 Langue
Groupes Item: BASELINE CONDITIONS, CCRR MODULE
Southwest Oncology Group BASELINE ASSESSMENT FORM (S0230) Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BEA4E960-6745-0470-E034-0003BA12F5E7

Breast Cancer NCT00659373 Pre-Study - Prior Treatment History Form (Form 24-H) - 2074666v3.0 - Prior Treatment History Form (Form 24-H)

- 09/01/2015 - 1 Formulaire, 3 Groupes Item, 25 Eléments de données, 1 Langue
Groupes Item: BEFORE DIAGNOSIS: CHEMOPREVENTION FOR BREAST CANCER, PRIOR CHEMOTHERAPY REGIMEN FOR BREAST CANCER, CCRR MODULE
Prior Treatment History Form (Form 24-H) Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG-2402 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1274765-836E-53AF-E034-0003BA12F5E7

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial